Charlotte M. Krieckaert
Amsterdam, NH 1056AB, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period.
Journal: The Lancet. Rheumatology
Published: August 29, 2022
COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases.
Journal: The Lancet. Rheumatology
Published: February 14, 2022
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider.
Journal: RMD open
Published: January 26, 2022
Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study.
Journal: RMD open
Published: October 15, 2021
The effect of methotrexate on tumour necrosis factor concentrations in etanercept-treated rheumatoid arthritis patients.
Journal: Rheumatology (Oxford, England)
Published: July 29, 2019
The effect of certolizumab drug concentration and anti-drug antibodies on TNF neutralisation.
Journal: Clinical and experimental rheumatology
Published: February 19, 2019
Efficacious transition from reference infliximab to biosimilar infliximab in clinical practice.
Journal: International journal of rheumatic diseases
Published: June 21, 2018
Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up.
Journal: PloS one
Published: April 23, 2018
Response to: Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial' by den Broeder et al.
Journal: Annals of the rheumatic diseases
Published: November 03, 2017
Long-term treatment response in rheumatoid arthritis patients starting adalimumab or etanercept with or without concomitant methotrexate.
Journal: Clinical and experimental rheumatology
Published: July 12, 2016
Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity.
Journal: Clinical and experimental rheumatology
Published: June 03, 2015
Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity.
Journal: The Journal of rheumatology
Published: May 14, 2015
Last Updated: 09/26/2026